1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Marc de Perrot: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection Durvalumab, Non-ablative oligofractionated radiation (NORT) - Lung Cancer Patients, Non-small Cell Lung Cancer (NSCLC) | Phase 2 | Unknown | Marc de Perrot | 12 | 2024-05-22 | 2024-07-22 |
| Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination Radiation: Varying Doses of RT - Transplant-Related Lung Cancer | Not applicable | Recruiting | Marc de Perrot | 30 | 2021-04-28 | 2026-09-10 |
Carcinoma, Non-Small-Cell Lung (1)
durvalumab (1)
Canada (2)